3042 companies

NextCell Pharma

Market Cap: SEK 107.5m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

NXTCL

SEK 0.96

7D

-3.3%

1Y

-42.2%

Marker Therapeutics

Market Cap: US$11.4m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

MRKR

US$0.95

7D

0%

1Y

-67.2%

HOOKIPA Pharma

Market Cap: US$11.3m

A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.

HOOK

US$0.93

7D

0.4%

1Y

-78.1%

Ghani Global Glass

Market Cap: PK₨3.2b

Engages in the manufacture and sale of glass tubes, glass wares, vials, ampules, and chemicals in Pakistan and Egypt.

GGGL

PK₨13.23

7D

1.2%

1Y

124.2%

Carisma Therapeutics

Market Cap: US$11.2m

A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.

CARM

US$0.29

7D

15.9%

1Y

-71.3%

Tissue Repair

Market Cap: AU$17.2m

A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.

TRP

AU$0.28

7D

3.6%

1Y

-20.8%

Nanologica

Market Cap: SEK 105.6m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

NICA

SEK 1.20

7D

1.7%

1Y

-48.0%

Artelo Biosciences

Market Cap: US$11.2m

A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.

ARTL

US$5.51

7D

-2.0%

1Y

-15.7%

DIOD Maker of Eco-Friendly Equipment and Nutrition

Market Cap: ₽677.1m

DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company researches, develops, manufactures, and sells nutritional supplements, pharmaceuticals, active cosmetics, and health equipment for home use.

DIOD

₽7.40

7D

0%

1Y

-13.5%

Zenith Capital

Market Cap: US$11.2m

A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.

ZHCL.F

US$0.10

7D

42.9%

1Y

0%

Pharmesis International

Market Cap: S$14.4m

An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.

BFK

S$0.46

7D

0%

1Y

261.1%

TME Pharma

Market Cap: €9.5m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

ALTME

€0.10

7D

9.0%

1Y

-25.0%

Abera Bioscience

Market Cap: SEK 104.4m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

ABERA

SEK 6.80

7D

-12.8%

1Y

70.0%

Quantumzyme

Market Cap: US$11.1m

Operates as a biotransformation company.

QTZM

US$0.28

7D

-2.6%

1Y

n/a

Mercury Laboratories

Market Cap: ₹982.3m

Engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally.

538964

₹818.55

7D

-2.7%

1Y

-19.8%

Cytophage Technologies

Market Cap: CA$15.4m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

CYTO

CA$0.24

7D

-2.0%

1Y

-2.0%

Sensei Biotherapeutics

Market Cap: US$11.1m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

SNSE

US$8.80

7D

-2.2%

1Y

-20.8%

XTL Biopharmaceuticals

Market Cap: ₪37.0m

A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.

XTLB

₪0.042

7D

2.4%

1Y

-55.3%

Althea Group Holdings

Market Cap: AU$16.9m

Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.

AGH

AU$0.02

7D

0%

1Y

-45.9%

PhoenixBio

Market Cap: JP¥1.6b

Provides contract study services for drug discovery and development primarily in Japan.

6190

JP¥407.00

7D

-1.9%

1Y

-8.1%

Eco-Growth Strategies

Market Cap: US$10.8m

Falcon Technologies, Inc. provides various design-build infrastructure services.

ECGS

US$0.20

7D

-2.5%

1Y

84.3%

Cardiogeni

Market Cap: UK£8.0m

A clinical stage biotechnology company, develops heart failure medicines.

CGNI

UK£0.09

7D

0%

1Y

n/a

Mediplantex National Pharmaceutical

Market Cap: ₫282.9b

Produces and trades in pharmaceutical products in Vietnam and internationally.

MED

₫22,800.00

7D

0%

1Y

-12.3%

Sharp Therapeutics

Market Cap: CA$15.0m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

SHRX

CA$0.50

7D

0%

1Y

n/a

4SC

Market Cap: €9.2m

A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany and internationally.

VSC

€0.84

7D

-17.5%

1Y

-84.2%

Bolt Biotherapeutics

Market Cap: US$10.6m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

BOLT

US$5.42

7D

3.6%

1Y

-56.3%

Bio Green Med Solution

Market Cap: US$10.6m

Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.

BGMS

US$5.15

7D

10.8%

1Y

-97.9%

Union Korea Pharm

Market Cap: ₩15.4b

Engages in the research, development, production, and sale of prescription drugs in South Korea.

A080720

₩2,725.00

7D

0%

1Y

-45.2%

Lyra Therapeutics

Market Cap: US$10.5m

A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.

LYRA

US$6.47

7D

1.9%

1Y

-51.3%

Evoke Pharma

Market Cap: US$10.5m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

EVOK

US$4.90

7D

-6.1%

1Y

1.9%

Matinas BioPharma Holdings

Market Cap: US$10.4m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

MTNB

US$1.90

7D

8.6%

1Y

-46.8%

Genomed Spólka Akcyjna

Market Cap: zł38.1m

Provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland.

GEN

zł28.80

7D

5.1%

1Y

4.3%

PExA

Market Cap: €8.9m

Develops and commercializes diagnostic products in various respiratory diseases.

FA0

€0.011

7D

-8.0%

1Y

-59.8%

Ludwig Enterprises

Market Cap: US$10.3m

Operates as a genomic technology and health related company in the United States.

LUDG

US$0.064

7D

-8.4%

1Y

-74.4%

Bharat Immunologicals & Biologicals

Market Cap: ₹914.1m

A biotechnology company, engages in the manufacture and sale of pharmaceutical products in India.

524663

₹21.17

7D

-3.5%

1Y

-28.4%

Firebrick Pharma

Market Cap: AU$15.7m

Engages in the development and commercializing of formulations for the uses of povidone iodine in Australia, the United states and Singapore.

FRE

AU$0.063

7D

-3.1%

1Y

5.0%

Page 64 of 85